Medical and Surgical Management of Central Retinal Vein Occlusion

International Ophthalmology Clinics

Volumn 44, Issue 1, 2004, Pages 1-16

  Sharma, Atul ^a   D'Amico, Donald J ^a  

^a MASSACHUSETTS EYE AND EAR INFIRMARY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALTEPLASE; ANTICOAGULANT AGENT; ANTITHROMBIN III; FIBRINOLYTIC AGENT; GLUCOCORTICOID; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; METHYLPREDNISOLONE SODIUM SUCCINATE; PHOSPHOLIPID ANTIBODY; PROTEIN C; PROTEIN S; STEROID; STREPTOKINASE; TRIAMCINOLONE ACETONIDE; UROKINASE; VASCULOTROPIN; WARFARIN;

ANTICOAGULANT THERAPY; ARGON LASER; BLINDNESS; BLOOD RETINA BARRIER; CENTRAL RETINA VEIN OCCLUSION; CONFERENCE PAPER; DIABETIC RETINOPATHY; ERBIUM YAG LASER; EXCIMER LASER; EYE SURGERY; FLUORESCENCE ANGIOGRAPHY; GLAUCOMA; HUMAN; LASER SURGERY; MICROINJECTION; NEODYMIUM LASER; PRIORITY JOURNAL; PROGNOSIS; PULSED ELECTRON AVALANCHE KNIFE; RETINA ISCHEMIA; RETINA MACULA EDEMA; RETINA NEOVASCULARIZATION; RETINA VEIN OCCLUSION; THROMBOGENESIS; VISUAL ACUITY; VITRECTOMY;

FIBRINOLYTIC AGENTS; GLUCOCORTICOIDS; HUMANS; OPHTHALMOLOGIC SURGICAL PROCEDURES; RETINAL VEIN OCCLUSION;

EID: 0842332566     PISSN: 00208167     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004397-200404410-00003     Document Type: Conference Paper

References (64)

1. Zegarra H, Gutman FA, Conforto J. The natural course of central retinal vein occlusion. Ophthalmology. 1979;86:1931-1942.
2. Quinlan PM, Elman MJ, Ghatt AK, et al. The natural course of central retinal vein occlusion. Am J Ophthalmol. 1990;110:118-123.
3. Hayreh SS, Rojus P, Podhajsky P, et al. Ocular neovascularization with retinal vascular occlusion: III, Incidence of ocular neovascularization with retinal vein occlusion. Ophthalmology. 1983;90:488-506.
4. Baseline and early natural history report. The Central Vein Occlusion Study. Arch Ophthalmol. 1993;111(8):1087-1095.
5. Green WR, Chan CC, Hutchins GM, et al. Central retinal vein occlusion: A prospective histopathologic study of 29 eyes in 28 cases. Trans Am Ophthalmol Soc. 1981;79:371-422.
6. Bick RL, Pegram M. Syndromes of hypercoagulability and thrombosis: A review. Semin Thromb Hemost. 1994;20:109-132.
7. Sperduto RD, Hiller R, Chew E, et al. Risk factors for hemiretinal vein occlusion: Comparison with risk factors for central and branch retinal vein occlusion: The eye disease case-control study. Ophthalmology. 1998;105:765-771.
8. Evaluation of grid pattern photocoagulation for macular edema in central vein occlusion. The Central Vein Occlusion Study Group M report. Ophthalmology. 1995;102(10): 1425-1433.
9. A randomized clinical trial of early panretinal photocoagulation for ischemic central vein occlusion. The Central Vein Occlusion Study Group N report. Ophthalmology. 1995;102(10):1434-1444.
10. Weiss JN, Bynoe LA. Injection of tissue plasminogen activator into a branch retinal vein in eyes with central retinal vein occlusion. Ophthalmology. 2001;108:2249-2257.
11. Weiss JN. Retinal surgery for treatment of central retinal vein occlusion. Ophthalmic Surg Lasers. 2000;31:162-165.
12. Vijayasekaran S, Yu DY, McAllister I, et al. Optimal conditions required for the creation of an iatrogenic chorioretinal venous anastomosis in the dog using argon green laser photocoagulation. Curr Eye Res. 1995;14:63-70.
13. McAllister IL, Douglas JP, Constable IJ, et al. Laser-induced chorioretinal venous anastomosis for nonischemic central retinal vein occlusion: Evaluation of the complications and their risk factors. Am J Ophthalmol. 1998;126:219-229.
14. McAllister IL, Constable IJ. Laser-induced chorioretinal venous anastomosis for treatment of nonischemic central retinal vein occlusion. Arch Ophthalmol. 1995;113:456-462.
15. Fekrat S, Goldberg MF, Finkelstein D. Laser-induced chorioretinal venous anastomosis for nonischemic central or branch retinal vein occlusion. Arch Ophthalmol. 1998;116:43-52.
16. Fekrat S, de Juan E Jr. Chorioretinal venous anastomosis for central retinal vein occlusion: Transvitreal venipuncture. Ophthalmic Surg Lasers. 1999;30:52-55.
17. Finkelstein D. Laser therapy for central retinal vein obstruction. Curr Opin Ophthalmol. 1996;7:80-83.
18. Browning, DJ, Antoszyk AN. Laser chorioretinal venous anastomosis for nonischemic central retinal vein occlusion. Ophthalmology. 1998;105(4):670-677; discussion 677-679.
19. Lit ES, Limbaris M, Gotzaridis E, et al. Lamina puncture: Pars plana optic disc surgery for central retinal vein occlusion. Arch Ophthalmol. 2002;120:495-499.
20. Opremcak EM, Bruce RA, Lomeo MD, et al. Radial optic neurotomy for central retinal vein occlusion: A retrospective pilot study of 11 consecutive cases. Retina. 2001;21:408-415.
21. Natural history and clinical management of central retinal vein occlusion. The Central Vein Occlusion Study Group. Arch Ophthalmol. 1997;115(4):486-491.
22. Fletcher DA, Palauker DV, Huie P, et al. Intravascular drug delivery with a pulsed liquid microjet. Arch Ophthalmol. 2002;120:1206-1208.
23. Quiroz-Mercado H, Sanchez-Buenfil E, Guerrero-Naranjo JL, et al. Successful erbium:YAG laser-induced chorioretinal venous anastomosis for the management of ischemic central retinal vein occlusion. A report of two cases. Graefes Arch Clin Exp Ophthalmol. 2001;239:872-875.
24. Eckstein M, McAllister I. Laser-induced chorioretinal venous anastomosis for non-ischaemic hemi-central vein occlusion. Clin Exp Ophthalmol. 2000;28:18-21.
25. McAllister IL, Vijayasekaran S, Yu DY, et al. Chorioretinal venous anastomoses: Effect of different laser methods and energy in human eyes without vein occlusion. Graefes Arch Clin Exp Ophthalmol. 1998;236:174-181.
26. Vijayasekaran S, Yu DY, McAllister I, et al. Significance of Bruch's membrane in the creation of iatrogenic chorioretinal venous anastomosis. Curr Eye Res. 1994;13:29-33.
27. McAllister IL, Yu DY, Vijayasekaran S, et al. Induced chorioretinal venous anastomosis in experimental retinal branch vein occlusion. Br J Ophthalmol. 1992;76:615-620.
28. Luttrull JK. Epiretinal membrane and traction retinal detachment complicating laser-induced chorioretinal venous anastomosis. Am J Ophthalmol. 1997;123:698-699.
29. Eccarius SG, Moran MJ, Slingsby JG. Choroidal neovascular membrane after laser-induced chorioretinal anastomosis. AmJ Ophthalmol. 1996;122:590-591.
30. Brazitikos PD, D'Amico DJ, Bernal MT, et al. Erbium:YAG laser surgery of the vitreous and retina. Ophthalmology. 1995;102:278-290.
31. Shaikh S, Blumenkranz MS. Transient improvement in visual acuity and macular edema in central retinal vein occlusion accompanied by inflammatory features after pulse steroid and anti-inflammatory therapy. Retina. 2001;21:176-178.
32. Doi M, Nakaseko Y, Uji Y, et al. Central retinal vein occlusion during remission of ulcerative colitis. Jpn J Ophthalmol. 1999;43:213-216.
33. Vandervliet SK. Papillophlebitis associated with systemic thrombophlebitis: Case report. Ann Ophthalmol. 1977;9:171-174.
34. Jonas JB, Kreissig I, Degenring RF. Intravitreal triamcinolone acetonide as treatment of macular edema in central retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol. 2002;240:782-783.
35. Wilson CA, Berkowitz BA, Sato Y, et al. Treatment with intravitreal steroid reduces blood-retinal barrier breakdown due to retinal photocoagulation. Arch Ophthalmol. 1992;110:1155-1159.
36. Ip MS, Kumar KS. Intravitreous triamcinolone acetonide as treatment for macular edema from central retinal vein occlusion. Arch Ophthalmol. 2002;120:1217-1219.
37. Greenberg PB, Martidis A, Rogers AH, et al. Intravitreal triamcinolone acetonide for macular oedema due to central retinal vein occlusion. Br J Ophthalmol. 2002;86:247-248.
38. Tano Y, Chandler D, Machemer R. Treatment of intraocular proliferation with intravitreal injection of triamcinolone acetonide. Am J Ophthalmol. 1980;90:810-816.
39. McCuen BW 2nd, Bessler M, Tano Y, et al. The lack of toxicity of intravitreally administered triamcinolone acetonide. AmJ Ophthalmol. 1981;91:785-788.
40. Danis RP, Ciulla TA, Pratt LM, et al. Intravitreal triamcinolone acetonide in exudative age-related macular degeneration. Retina. 2000;20:244-250.
41. Antcliff RJ, Spalton DJ, Stanford MR, et al. Intravitreal triamcinolone for uveitic cystoid macular edema: An optical coherence tomography study. Ophthalmology. 2001;108:765-772.
42. Jonas JB, Sofker A. Intraocular injection of crystalline cortisone as adjunctive treatment of diabetic macular edema. Am J Ophthalmol. 2001;132:425-427.
43. Jonas JB, Hayler JK, Sofker A, et al. Intravitreal injection of crystalline cortisone as adjunctive treatment of proliferative diabetic retinopathy. Am J Ophthalmol. 2001;131:468-471.
44. den Ottolander GJ, Craandijk A. Treatment of thrombosis of the central retinal vein with streptokinase. Thromb Diath Haemorrh. 1968;20:415-419.
45. Ota R, Okisaka S. Effects of anticoagulant therapy on retinal vein occlusion. Nippon Ganka Gakkai Zasshi. 1995;99:955-958.
46. Furuta M, Sekiryu T, Sato H, et al. Warfarin potassium for impending central retinal vein occlusion. Nippon Ganka Gakkai Zasshi. 1999;103:124-128.
47. Kohner EM, Pettit JE, Hamilton AM, et al. Streptokinase in central retinal vein occlusion: A controlled clinical trial. Br Med J. 1976;1:550-553.
48. Vannas S, Raitta C. On anticoagulant treatment of central venous occlusion of the retina. Acta Ophthalmol (Copenh) 1968;46:730-735
49. Verstraete M, Bernard R, Bory M, et al. Randomised trial of intravenous recombinant tissue-type plasminogen activator versus intravenous streptokinase in acute myocardial infarction. Report from the European Cooperative Study Group for Recombinant Tissue-type Plasminogen Activator. Lancet. 1985;1:842-847.
50. The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings. TIMI Study Group. N Engl J Med. 1985;312(14):932-936.
51. Chesebro JH, Knatterud G, Roberts R, et al. Thrombolysis in Myocardial Infarction (TIMI) Trial: Phase I. A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge. Circulation. 1987;76:142-154.
52. Oncel M, Peyman GA, Khoobehi B. Tissue plasminogen activator in the treatment of experimental retinal vein occlusion. Retina. 1989;9:1-7.
53. Elman MJ. Thrombolytic therapy for central retinal vein occlusion: Results of a pilot study. Trans Am Ophthalmol Soc. 1996;94:471-504.
54. Elman, MJ, Raden RZ, Carrigan A. Intravitreal injection of tissue plasminogen activator for central retinal vein occlusion. Trans Am Ophthalmol Soc. 2001;99:219-221; discussion 222-223.
55. Glacet-Bernard A, Kuhn D, Vine AK, et al. Treatment of recent onset central retinal vein occlusion with intravitreal tissue plasminogen activator: A pilot study. Br J Ophthalmol. 2000;84:609-613.
56. Lahey JM, Fong DS, Kearney J. Intravitreal tissue plasminogen activator for acute central retinal vein occlusion. Ophthalmic Surg Lasers. 1999;30:427-434.
57. Loscalzo J, Braunwald E. Tissue plasminogen activator. N Engl J Med. 1988;319:925-931.
58. Hayreh SS. t-PA in CRVO. Ophthalmology. 2002;109(10):1758-1761; author reply 1761-1763.
59. Hayreh SS, Opremcak EM. Radial optic neurotomy for central retinal vein occlusion. Retina. 2002;22:827.
60. Palanker DV, Miller JM, Marmor MF, et al. Pulsed electron avalanche knife (PEAK) for intraocular surgery. Invest Ophthalmol Vis Sci. 2001;42:2673-2678.
61. Vogel A, Capon MR, Asiyo-Vogel MN, et al. Intraocular photodisruption with picosecond and nanosecond laser pulses: Tissue effects in cornea, lens, and retina. Invest Ophthalmol Vis Sci. 1994;35:3032-3044.
62. Brazitikos PD, D'Amico DJ, Bochow TW, et al. Experimental ocular surgery with a high-repetition-rate erbium:YAG laser. Invest Ophthalmol Vis Sci. 1998;39:1667-1675.
63. Martidis A, Duker JS, Puliafito CA. Intravitreal triamcinolone for refractory cystoid macular edema secondary to birdshot retinochoroidopathy. Arch Ophthalmol. 2001;119:1380-1383.
64. Young S, Larkin G, Branley M, et al. Safety and efficacy of intravitreal triamcinolone for cystoid macular oedema in uveitis. Clin Exp Ophthalmol. 2001;29:2-6.